Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Structural Heart Disease: Key SCAI 2022 updates | Creating an integrated heart team program
Thursday, June 9, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists

The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.

READ MORE >
SCAI 2022 interventional cardiology TAVR CTO PCI TPV cath labs
Share on Twitter Share on Facebook Share on Linkedin

TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists

Share on Twitter Share on Facebook Share on Linkedin
SCAI 2022 interventional cardiology TAVR CTO PCI TPV cath labs
The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.
READ MORE >

VIDEO: Creating an integrated heart team program in central Texas

Charles D. Fraser, Jr., MD, executive director of the new Institute for Cardiovascular Health in Austin, Texas, discusses the facility's new, state-of-the-art cardiology program.

READ MORE >
Charles D. Fraser, Jr., MD, executive director of the new Institute for Cardiovascular Health, a collaboration between Ascension Texas and the University of Texas at Austin, including its Dell Medical School. This new, state-of-the-art cardiology program fully integrates all the cardiac subspecialties to create a comprehensive heart team approach in treating patients.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Creating an integrated heart team program in central Texas

Share on Twitter Share on Facebook Share on Linkedin
Charles D. Fraser, Jr., MD, executive director of the new Institute for Cardiovascular Health, a collaboration between Ascension Texas and the University of Texas at Austin, including its Dell Medical School. This new, state-of-the-art cardiology program fully integrates all the cardiac subspecialties to create a comprehensive heart team approach in treating patients.
Charles D. Fraser, Jr., MD, executive director of the new Institute for Cardiovascular Health in Austin, Texas, discusses the facility's new, state-of-the-art cardiology program.
READ MORE >

Is TAVR a sensible choice for patients with moderate, symptomatic aortic stenosis? Medtronic aims to find out

The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.

READ MORE >
TAVR Medtronic Evolut EXPAND TAVR II Pivotal Trial will study the use of T AVR in patients with moderate, symptomatic aortic stenosis.
Share on Twitter Share on Facebook Share on Linkedin

Is TAVR a sensible choice for patients with moderate, symptomatic aortic stenosis? Medtronic aims to find out

Share on Twitter Share on Facebook Share on Linkedin
TAVR Medtronic Evolut EXPAND TAVR II Pivotal Trial will study the use of T AVR in patients with moderate, symptomatic aortic stenosis.
The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.
READ MORE >

Late balloon valvuloplasty safe and effective for patients with THV dysfunction

The median time from heart valve implantation to balloon dilatation was 4.6 months.

READ MORE >
Balloon valvuloplasty months after implantation is a safe and effective treatment option for patients with transcatheter heart valve (THV) dysfunction, according to a new analysis published in the Journal of the American College of Cardiology
Share on Twitter Share on Facebook Share on Linkedin

Late balloon valvuloplasty safe and effective for patients with THV dysfunction

Share on Twitter Share on Facebook Share on Linkedin
Balloon valvuloplasty months after implantation is a safe and effective treatment option for patients with transcatheter heart valve (THV) dysfunction, according to a new analysis published in the Journal of the American College of Cardiology
The median time from heart valve implantation to balloon dilatation was 4.6 months.
READ MORE >

Mitral annulus calcification more than doubles a patient’s risk of heart valve disease

"For clinicians, suspicion for valve diseases should be increased and evaluations carefully performed for patients with MAC," according to one Mayo Clinic cardiologist.

READ MORE >
Examples of mitral annulus calcification (MAC) visualized using echocardiography. Image from the journal Echocardiography.
Share on Twitter Share on Facebook Share on Linkedin

Mitral annulus calcification more than doubles a patient’s risk of heart valve disease

Share on Twitter Share on Facebook Share on Linkedin
Examples of mitral annulus calcification (MAC) visualized using echocardiography. Image from the journal Echocardiography.
"For clinicians, suspicion for valve diseases should be increased and evaluations carefully performed for patients with MAC," according to one Mayo Clinic cardiologist.
READ MORE >

Transcatheter PVL closure linked to lower 30-day mortality than surgery

Long-term mortality, meanwhile, is similar between the two treatment options.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Transcatheter PVL closure linked to lower 30-day mortality than surgery

Share on Twitter Share on Facebook Share on Linkedin
Long-term mortality, meanwhile, is similar between the two treatment options.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme